Literature DB >> 11687458

Anemia and interleukin-10, tumor necrosis factor alpha, and erythropoietin levels among children with acute, uncomplicated Plasmodium falciparum malaria.

V Nussenblatt1, G Mukasa, A Metzger, G Ndeezi, E Garrett, R D Semba.   

Abstract

Anemia is an important complication of malaria, and its pathogenesis is not well understood. To gain insight into potential age-related relationships between tumor necrosis factor alpha (TNF-alpha), interleukin 10 (IL-10), erythropoietin, and anemia during acute malaria, 273 children of ages 12 to 120 months presenting with acute, uncomplicated malaria in Kampala, Uganda, were monitored at enrollment and 3 and 7 days later. Younger children had higher geometric mean erythropoietin, TNF-alpha, and alpha(1)-acid glycoprotein (AGP) concentrations than older children. Univariate regression analysis revealed that age, log(10) erythropoietin levels, IL-10/TNF-alpha ratio, and AGP levels were each significantly associated with hemoglobin levels at baseline. Hemoglobin concentrations were inversely correlated with the log(10) erythropoietin level at all three visits. For the older age groups, higher levels of TNF-alpha were significantly associated with higher IL-10 levels at all three visits, but this relationship was significant only at baseline for younger children. These data suggest that younger children do not maintain IL-10 production in response to the inflammatory process, and this mechanism may contribute to the more severe anemia found in younger children. Acute malaria is an illness whose incidence and severity are largely age dependent. Further studies are needed to understand the relationships between age-related immune responses to malaria and their role in the pathogenesis of malarial anemia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11687458      PMCID: PMC96244          DOI: 10.1128/CDLI.8.6.1164-1170.2001

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  37 in total

1.  Plasma interleukin-10:Tumor necrosis factor (TNF)-alpha ratio is associated with TNF promoter variants and predicts malarial complications.

Authors:  J May; B Lell; A J Luty; C G Meyer; P G Kremsner
Journal:  J Infect Dis       Date:  2000-10-09       Impact factor: 5.226

2.  Reversible suppression of bone marrow response to erythropoietin in Plasmodium falciparum malaria.

Authors:  J A Kurtzhals; O Rodrigues; M Addae; J O Commey; F K Nkrumah; L Hviid
Journal:  Br J Haematol       Date:  1997-04       Impact factor: 6.998

3.  Distinct patterns of cytokine regulation in discrete clinical forms of Plasmodium falciparum malaria.

Authors:  B D Akanmori; J A Kurtzhals; B Q Goka; V Adabayeri; M F Ofori; F K Nkrumah; C Behr; L Hviid
Journal:  Eur Cytokine Netw       Date:  2000-03       Impact factor: 2.737

4.  Endogenous interleukin-10 modulates proinflammatory response in Plasmodium falciparum malaria.

Authors:  M Ho; T Schollaardt; S Snape; S Looareesuwan; P Suntharasamai; N J White
Journal:  J Infect Dis       Date:  1998-08       Impact factor: 5.226

5.  Plasmodium chabaudi chabaudi: differential susceptibility of gene-targeted mice deficient in IL-10 to an erythrocytic-stage infection.

Authors:  A Linke; R Kühn; W Müller; N Honarvar; C Li; J Langhorne
Journal:  Exp Parasitol       Date:  1996-11       Impact factor: 2.011

6.  Involvement of the acute phase protein alpha 1-acid glycoprotein in nonspecific resistance to a lethal gram-negative infection.

Authors:  T Hochepied; W Van Molle; F G Berger; H Baumann; C Libert
Journal:  J Biol Chem       Date:  2000-05-19       Impact factor: 5.157

7.  Low interleukin-12 activity in severe Plasmodium falciparum malaria.

Authors:  A J Luty; D J Perkins; B Lell; R Schmidt-Ott; L G Lehman; D Luckner; B Greve; P Matousek; K Herbich; D Schmid; J B Weinberg; P G Kremsner
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

8.  Tumor necrosis factor in Plasmodium falciparum malaria: high plasma level is associated with fever, but high production capacity is associated with rapid fever clearance.

Authors:  B G Mordmüller; W G Metzger; P Juillard; B M Brinkman; C L Verweij; G E Grau; P G Kremsner
Journal:  Eur Cytokine Netw       Date:  1997-03       Impact factor: 2.737

9.  A low interleukin-10 tumor necrosis factor-alpha ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya.

Authors:  C Othoro; A A Lal; B Nahlen; D Koech; A S Orago; V Udhayakumar
Journal:  J Infect Dis       Date:  1999-01       Impact factor: 5.226

10.  Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria.

Authors:  J A Kurtzhals; V Adabayeri; B Q Goka; B D Akanmori; J O Oliver-Commey; F K Nkrumah; C Behr; L Hviid
Journal:  Lancet       Date:  1998-06-13       Impact factor: 79.321

View more
  24 in total

1.  Dual role of erythrocyte complement receptor type 1 in immune complex-mediated macrophage stimulation: implications for the pathogenesis of Plasmodium falciparum malaria.

Authors:  M Odera; W Otieno; C Adhiambo; J A Stoute
Journal:  Clin Exp Immunol       Date:  2011-11       Impact factor: 4.330

2.  Distinct clinical and immunologic profiles in severe malarial anemia and cerebral malaria in Zambia.

Authors:  Philip E Thuma; Janneke van Dijk; Rick Bucala; Zufan Debebe; Sergei Nekhai; Thea Kuddo; Mehdi Nouraie; Günter Weiss; Victor R Gordeuk
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

3.  Mechanisms of erythropoiesis inhibition by malarial pigment and malaria-induced proinflammatory mediators in an in vitro model.

Authors:  Gordon A Awandare; Prakasha Kempaiah; Daniel O Ochiel; Paolo Piazza; Christopher C Keller; Douglas J Perkins
Journal:  Am J Hematol       Date:  2011-02       Impact factor: 10.047

4.  A novel functional variant in the stem cell growth factor promoter protects against severe malarial anemia.

Authors:  Collins Ouma; Christopher C Keller; Gregory C Davenport; Tom Were; Stephen Konah; Michael F Otieno; James B Hittner; John M Vulule; Jeremy Martinson; John M Ong'echa; Robert E Ferrell; Douglas J Perkins
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

5.  Reduced systemic bicyclo-prostaglandin-E2 and cyclooxygenase-2 gene expression are associated with inefficient erythropoiesis and enhanced uptake of monocytic hemozoin in children with severe malarial anemia.

Authors:  Samuel B Anyona; Prakasha Kempaiah; Evans Raballah; Gregory C Davenport; Tom Were; Stephen N Konah; John M Vulule; James B Hittner; Charity W Gichuki; John M Ong'echa; Douglas J Perkins
Journal:  Am J Hematol       Date:  2012-06-23       Impact factor: 10.047

6.  Whole-Blood Transcriptional Signatures Composed of Erythropoietic and NRF2-Regulated Genes Differ Between Cerebral Malaria and Severe Malarial Anemia.

Authors:  Srinivas Nallandhighal; Gregory S Park; Yen-Yi Ho; Robert O Opoka; Chandy C John; Tuan M Tran
Journal:  J Infect Dis       Date:  2019-01-01       Impact factor: 5.226

7.  Role of monocyte-acquired hemozoin in suppression of macrophage migration inhibitory factor in children with severe malarial anemia.

Authors:  Gordon A Awandare; Yamo Ouma; Collins Ouma; Tom Were; Richard Otieno; Christopher C Keller; Gregory C Davenport; James B Hittner; John Vulule; Robert Ferrell; John M Ong'echa; Douglas J Perkins
Journal:  Infect Immun       Date:  2006-10-23       Impact factor: 3.441

Review 8.  Pathogenesis of anemia in malaria: a concise review.

Authors:  Kanjaksha Ghosh; Kinjalka Ghosh
Journal:  Parasitol Res       Date:  2007-09-16       Impact factor: 2.289

9.  Defective erythropoietin production and reticulocyte response in acute Plasmodium falciparum malaria-associated anemia.

Authors:  Wattana Leowattana; Srivicha Krudsood; Noppadon Tangpukdee; Gary Brittenham; Sornchai Looareesuwan
Journal:  Southeast Asian J Trop Med Public Health       Date:  2008-07       Impact factor: 0.267

10.  Age-related changes in adaptation to severe anemia in childhood in developing countries.

Authors:  Angela O'Donnell; A Premawardhena; M Arambepola; S J Allen; T E A Peto; C A Fisher; D C Rees; Nancy F Olivieri; D J Weatherall
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.